Form 4: Quest Diagnostics Executive Sam Samad Reports Stock Acquisition Through Dividend Reinvestment

Executive Vice President & CFO of Quest Diagnostics, Sam Samad, reports acquiring 74 shares of common stock through a dividend reinvestment plan at a price of $164.422 per share.

Summary

• Sam Samad, Executive Vice President & CFO of Quest Diagnostics, filed a Form 4 to report changes in beneficial ownership.
• On April 21, 2025, Mr. Samad acquired 74 shares of Quest Diagnostics common stock through a dividend reinvestment plan.
• The price per share was $164.422.
• Following the transaction, Mr. Samad directly owns 26,451 shares of Quest Diagnostics common stock.
• The reporting person has chosen to report such transaction early on this Form 4.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as the transaction reflects the executive's continued investment in the company through a dividend reinvestment plan.

Positives

• The executive's participation in the dividend reinvestment plan demonstrates confidence in the company's future.

Industry Context

Dividend reinvestment plans are a common way for employees and executives to increase their stake in a company, aligning their interests with those of shareholders.

Stakeholder Impact

• The transaction signals to shareholders that the executive has confidence in the company's performance.

Key Dates

Keywords

Form 4, Quest Diagnostics, Sam Samad, Dividend Reinvestment, Beneficial Ownership, Executive Compensation, DGX